JOINT FILING AGREEMENTJoint Filing Agreement • October 5th, 2015 • MacAndrews & Forbes Inc. • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D and any amendments thereto relating to shares of the Class A common stock, par value $0.01 per share (the “Class A Common Stock”), of vTv Therapeutics Inc., a company incorporated under the laws of Delaware. This Joint Filing Agreement shall be included as an Exhibit to such joint filing, and may be executed in any number of counterparts all of which together shall constitute one and the same instrument.
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • October 5th, 2015 • MacAndrews & Forbes Inc. • Pharmaceutical preparations • Delaware
This Agreement and Plan of Merger (this “Agreement”), dated as of October 1, 2015, by and among vTv Therapeutics Holdings LLC, a Delaware limited liability company (“Holdings”), vTvx Holdings I LLC (f/k/a TransTech Pharma, LLC), a Delaware limited liability company (“TTP”), and vTvx Holdings II LLC (f/k/a High Point Pharmaceuticals LLC), a Delaware limited liability company (“HPP” and together with TTP, collectively, the “Companies”).
